Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.43B |
| 2 |
Chevron
CVX
|
+$314M |
| 3 |
ExxonMobil
XOM
|
+$282M |
| 4 |
Tesla
TSLA
|
+$253M |
| 5 |
Warner Bros
WBD
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$278M |
| 2 |
CERN
Cerner Corp
CERN
|
+$275M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$149M |
| 4 |
Baidu
BIDU
|
+$137M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.42% |
| 2 | Healthcare | 14.2% |
| 3 | Financials | 13.14% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Ginkgo Bioworks
DNA
$521M
| $599K | ﹤0.01% |
+6,288
| New | +$767K |
|
2302
TG Therapeutics
TGTX
$7.62B
| $599K | ﹤0.01% |
140,981
+31,529
| +29% | +$197K |
|
2303
Enterprise Financial Services Corp
EFSC
$2.39B
| $592K | ﹤0.01% |
14,244
+144
| +1% | +$6.41K |
|
2304
Immunocore
IMCR
$1.73B
| $589K | ﹤0.01% |
15,792
-6,577
| -29% | -$214K |
|
2305
Hudbay
HBM
$12.3B
| $588K | ﹤0.01% |
144,592
+1,050
| +0.7% | +$6.27K |
|
|
TEN
2306
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $588K | ﹤0.01% |
34,253
+3,845
| +13% | +$64.9K |
|
|
CSW
2307
CSW Industrials
CSW
$5.71B
| $578K | ﹤0.01% |
5,609
-126
| -2% | -$13.4K |
|
|
RVNC
2308
DELISTED
Revance Therapeutics, Inc.
RVNC
| $575K | ﹤0.01% |
41,619
-281
| -0.7% | -$4.33K |
|
2309
Comtech Telecommunications
CMTL
$51.8M
| $568K | ﹤0.01% |
62,687
-565
| -0.9% | -$7.06K |
|
2310
Kymera Therapeutics
KYMR
$8.94B
| $565K | ﹤0.01% |
28,703
+258
| +0.9% | +$6.03K |
|
2311
TriCo Bancshares
TCBK
$1.83B
| $564K | ﹤0.01% |
12,357
-446
| -3% | -$18.8K |
|
|
CNR
2312
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $563K | ﹤0.01% |
22,964
+1,564
| +7% | +$38.1K |
|
2313
International Money Express
IMXI
$367M
| $556K | ﹤0.01% |
27,183
-8,008
| -23% | -$161K |
|
2314
Community Trust Bancorp
CTBI
$1.41B
| $549K | ﹤0.01% |
13,567
-627
| -4% | -$25.5K |
|
2315
Stevanato
STVN
$5.54B
| $549K | ﹤0.01% |
34,628
+22,073
| +176% | +$365K |
|
2316
Travere Therapeutics
TVTX
$5.78B
| $548K | ﹤0.01% |
22,601
+957
| +4% | +$24.1K |
|
2317
Cimpress
CMPR
$2.31B
| $547K | ﹤0.01% |
14,066
-402
| -3% | -$19.6K |
|
2318
Microvision
MVIS
$78.9M
| $546K | ﹤0.01% |
9,485
+17
| +0.2% | +$911 |
|
2319
Rocket Pharmaceuticals
RCKT
$394M
| $536K | ﹤0.01% |
38,973
+9,274
| +31% | +$111K |
|
2320
Theravance Biopharma
TBPH
$877M
| $534K | ﹤0.01% |
58,904
+1,516
| +3% | +$14K |
|
2321
Marathon Digital Holdings
MARA
$3.9B
| $533K | ﹤0.01% |
99,788
+14,984
| +18% | +$200K |
|
|
PAYA
2322
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $532K | ﹤0.01% |
80,892
-5,121
| -6% | -$28.8K |
|
2323
Liberty Latin America Class A
LILA
$1.67B
| $531K | ﹤0.01% |
100,114
-9,385
| -9% | -$58.5K |
|
2324
Suzano
SUZ
$10.1B
| $523K | ﹤0.01% |
55,121
| – | – |
|
2325
Freedom Holding
FRHC
$9.49B
| $522K | ﹤0.01% |
11,768
+183
| +2% | +$8.41K |
|
Similar funds
Legal & General Group's Q2 2022 Portfolio in Review
As of Q2 2022, Legal & General Group held 3,787 positions worth $283B, down 14% from $329B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group's Q2 2022 filing shows 222 new, 1,979 increased, 1,147 reduced and 274 closed positions. Its largest new stake was Samsara: 1,199,080 shares worth $13.4M. The largest sale was AT&T, an estimated $278M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q2 2022 buy was Samsara: 1,199,080 shares worth $13.4M.
- Legal & General Group added most to Apple in Q2 2022, an estimated $1.43B increase.
- Legal & General Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $278M.
- Legal & General Group fully exited Cerner Corp in Q2 2022, selling an estimated $275M.
- Legal & General Group's ten largest holdings make up 22% of its $283B portfolio in Q2 2022.
- Legal & General Group opened 222 new positions and closed 274 in Q2 2022.
- Legal & General Group's portfolio value fell 14% quarter-over-quarter to $283B.
Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.